State Of Wisconsin Investment Board Cabaletta Bio, Inc. Transaction History

State Of Wisconsin Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.22 - $18.82 $3,963 - $10,332	-549 Reduced 2.65%	20,191 $151,000
Q1 2024 May 14, 2024	SELL	$16.79 - $25.38 $38,835 - $58,703	-2,313 Reduced 10.03%	20,740 $353,000
Q4 2023 Feb 12, 2024	SELL	$12.21 - $23.36 $69,059 - $132,124	-5,656 Reduced 19.7%	23,053 $523,000
Q3 2023 Nov 14, 2023	BUY	$11.84 - $18.65 $339,914 - $535,422	28,709 New	28,709 $436,000
Q2 2021 Aug 12, 2021	SELL	$7.2 - $11.73 $130,320 - $212,313	-18,100 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$9.81 - $15.8 $177,561 - $285,980	18,100 New	18,100 $226,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.